247 related articles for article (PubMed ID: 35653814)
21. Dravet Syndrome: Diagnosis and Long-Term Course.
Connolly MB
Can J Neurol Sci; 2016 Jun; 43 Suppl 3():S3-8. PubMed ID: 27264139
[TBL] [Abstract][Full Text] [Related]
22. A novel rat model of Dravet syndrome recapitulates clinical hallmarks.
Li M; Yang L; Qian W; Ray S; Lu Z; Liu T; Zou YY; Naumann RK; Wang H
Neurobiol Dis; 2023 Aug; 184():106193. PubMed ID: 37295561
[TBL] [Abstract][Full Text] [Related]
23. Defining Dravet syndrome: An essential pre-requisite for precision medicine trials.
Li W; Schneider AL; Scheffer IE
Epilepsia; 2021 Sep; 62(9):2205-2217. PubMed ID: 34338318
[TBL] [Abstract][Full Text] [Related]
24. Identification of novel and de novo variant in the SCN1A gene confirms Dravet syndrome in Moroccan child: a case report.
El Mouhi H; Amllal N; Abbassi M; Nedbour A; Jalte M; Lyahyai J; Chafai Elalaoui S; Bouguenouch L; Chaouki S
Mol Biol Rep; 2024 Jan; 51(1):233. PubMed ID: 38282049
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic spectrum of the SCN1A mutation (from febrile seizures to Dravet syndrome).
Ceska K; Danhofer P; Horak O; Spanelova K; Kolar S; Oslejskova H; Aulicka S
Bratisl Lek Listy; 2022; 123(7):483-486. PubMed ID: 35907053
[TBL] [Abstract][Full Text] [Related]
26. Genetic Diagnosis of Dravet Syndrome Using Next Generation Sequencing-Based Epilepsy Gene Panel Testing.
Lee J; Lee C; Park WY; Lee J
Ann Clin Lab Sci; 2020 Sep; 50(5):625-637. PubMed ID: 33067208
[TBL] [Abstract][Full Text] [Related]
27. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
[TBL] [Abstract][Full Text] [Related]
28. Dravet syndrome and parkinsonism: A case report investigating the dopaminergic system.
Deuel L; Collins AE; Maa EH; Barr JP; Kern DS
Neurology; 2019 Sep; 93(13):595-596. PubMed ID: 31444242
[No Abstract] [Full Text] [Related]
29. The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009.
Bayat A; Hjalgrim H; Møller RS
Epilepsia; 2015 Apr; 56(4):e36-9. PubMed ID: 25778844
[TBL] [Abstract][Full Text] [Related]
30. SCN1A as a therapeutic target for Dravet syndrome.
Myers KA
Expert Opin Ther Targets; 2023; 27(6):459-467. PubMed ID: 37364240
[TBL] [Abstract][Full Text] [Related]
31. SCN1A-related phenotypes: Epilepsy and beyond.
Scheffer IE; Nabbout R
Epilepsia; 2019 Dec; 60 Suppl 3():S17-S24. PubMed ID: 31904117
[TBL] [Abstract][Full Text] [Related]
32. Viral vector-mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome.
Fadila S; Beucher B; Dopeso-Reyes IG; Mavashov A; Brusel M; Anderson K; Ismeurt C; Goldberg EM; Ricobaraza A; Hernandez-Alcoceba R; Kremer EJ; Rubinstein M
J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37192002
[TBL] [Abstract][Full Text] [Related]
33. Antisense oligonucleotides increase
Han Z; Chen C; Christiansen A; Ji S; Lin Q; Anumonwo C; Liu C; Leiser SC; Meena ; Aznarez I; Liau G; Isom LL
Sci Transl Med; 2020 Aug; 12(558):. PubMed ID: 32848094
[TBL] [Abstract][Full Text] [Related]
34. Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome.
Rubinstein M; Westenbroek RE; Yu FH; Jones CJ; Scheuer T; Catterall WA
Neurobiol Dis; 2015 Jan; 73():106-17. PubMed ID: 25281316
[TBL] [Abstract][Full Text] [Related]
35. Dravet syndrome and Dravet syndrome-like phenotype: a systematic review of the SCN1A and PCDH19 variants.
Rampazzo ACM; Dos Santos RRP; Maluf FA; Simm RF; Marson FAL; Ortega MM; de Aguiar PHP
Neurogenetics; 2021 May; 22(2):105-115. PubMed ID: 33937968
[TBL] [Abstract][Full Text] [Related]
36. Prediction of molecular phenotypes for novel SCN1A variants from a Turkish genetic epilepsy syndromes cohort and report of two new patients with recessive Dravet syndrome.
Teralı K; Türkyılmaz A; Sağer SG; Çebi AH
Clin Transl Sci; 2024 Jan; 17(1):e13679. PubMed ID: 37955180
[TBL] [Abstract][Full Text] [Related]
37. Adult motor phenotype differentiates Dravet syndrome from Lennox-Gastaut syndrome and links SCN1A to early onset parkinsonian features.
Aljaafari D; Fasano A; Nascimento FA; Lang AE; Andrade DM
Epilepsia; 2017 Mar; 58(3):e44-e48. PubMed ID: 28186331
[TBL] [Abstract][Full Text] [Related]
38. Investigation of MicroRNA-134 as a Target against Seizures and SUDEP in a Mouse Model of Dravet Syndrome.
Gerbatin RR; Augusto J; Morris G; Campbell A; Worm J; Langa E; Reschke CR; Henshall DC
eNeuro; 2022; 9(5):. PubMed ID: 36240080
[TBL] [Abstract][Full Text] [Related]
39. Hippocampal deletion of Na
Stein RE; Kaplan JS; Li J; Catterall WA
Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16571-16576. PubMed ID: 31346088
[TBL] [Abstract][Full Text] [Related]
40. Musicogenic seizures in Dravet syndrome.
Sanchez-Carpintero R; Patiño-Garcia A; Urrestarazu E
Dev Med Child Neurol; 2013 Jul; 55(7):668-70. PubMed ID: 23517304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
